Xiaoli Shen
Nanchang, 330006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
RBM43 promotes glioma aggressiveness and shapes the immune microenvironment through macrophage polarization.
Journal: Discover oncology
Published: February 04, 2026
Advances in the Understanding and Mechanisms of Cabergoline-induced Valvulopathy in Prolactinoma Patients.
Journal: Mini reviews in medicinal chemistry
Published: July 20, 2025
PSMB2 plays an oncogenic role in glioma and correlates to the immune microenvironment.
Journal: Scientific reports
Published: December 07, 2023
Correction to: Construction of a competitive endogenous RNA network and analysis of potential regulatory axis targets in glioblastoma.
Journal: Cancer cell international
Published: August 19, 2023
Decapping enzyme 2 is a novel immune-related biomarker that predicts poor prognosis in glioma.
Journal: Biotechnology & genetic engineering reviews
Published: May 16, 2023
Regulatory role of JMJD6 in placental development.
Journal: Expert reviews in molecular medicine
Published: October 12, 2022
Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis.
Journal: Frontiers in genetics
Published: September 25, 2022
Expression, methylation and prognostic feature of EMILIN2 in Low-Grade-Glioma.
Journal: Brain research bulletin
Published: March 22, 2021
Three-Dimensional Radiomics Features From Multi-Parameter MRI Combined With Clinical Characteristics Predict Postoperative Cerebral Edema Exacerbation in Patients With Meningioma.
Journal: Frontiers in oncology
Published: November 02, 2020
Construction of a competitive endogenous RNA network and analysis of potential regulatory axis targets in glioblastoma.
Journal: Cancer cell international
Published: September 14, 2020
Last Updated: 09/26/2026